Related Experiment Videos
Kawasaki disease. Epidemiology, late prognosis, and therapy
1Section of Pediatric Rheumatology, Baylor College of Medicine, Houston, Texas.
Insights
Kawasaki disease, a childhood vasculitis, can lead to coronary artery aneurysms in 20% of cases. Most aneurysms regress, especially in infants, with aspirin and IVIG therapy recommended.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Cardiovascular Medicine
Background:
- Kawasaki disease is an immune-mediated vasculitis affecting children, with unknown origins.
- While symptoms like rash and fever are transient, coronary artery aneurysms pose a significant risk, potentially leading to thrombotic complications in up to 20% of affected children.
- The exact infectious trigger remains unidentified, but an aberrant immune response is crucial to disease progression.
Purpose of the Study:
- To review the clinical features, etiology, and cardiovascular complications of Kawasaki disease.
- To discuss the natural history and regression factors of coronary artery aneurysms.
- To outline current therapeutic recommendations, including aspirin and intravenous immunoglobulin (IVIG).
Main Methods:
- Literature review of Kawasaki disease studies.
- Analysis of epidemiological and clinical data.
- Summary of treatment guidelines and outcomes.
Main Results:
- Kawasaki disease presents with inflammation, rash, and lymphadenopathy, but carries a risk of coronary artery aneurysms.
- Coronary artery aneurysms often regress spontaneously, with factors like younger age and aneurysm characteristics influencing regression.
- Aspirin and IVIG are standard treatments, with varying dosage regimens discussed.
Conclusions:
- Kawasaki disease requires prompt recognition due to potential cardiovascular sequelae.
- Early diagnosis and treatment are crucial for managing coronary artery aneurysms.
- Ongoing research is needed to identify the specific etiology and optimize treatment strategies.
Abstract:
Kawasaki disease is an immunologically mediated diffuse vasculitis of childhood of unknown etiology. While most of the clinical features--including diffuse mucosal inflammation, indurative edema, rash, and lymphadenopathy--are self-limiting, coronary artery aneurysms and the possibility of thrombotic occlusion occurs in up to 20% of children. The epidemiologic and clinical features of this disease suggest an infectious etiology; however, a specific organism has not been consistently identified. An abnormal immune response to this as yet to be defined organism plays a critical role in the progression of this disease. The morbidity and mortality of this disease are related primarily to the potential cardiovascular complications. The natural history of the coronary artery aneurysms is that most lesions regress with time. Factors leading to a higher probability of regression include age less than 1 year, female sex, fusiform aneurysm, and maximum diameter less than 4 mm. Current recommendations for therapy include aspirin and IVIG. The range of dosages regimens for each medication are discussed in the text.